(Q61867795)

English

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial

scientific article published in May 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

based on heuristic

inferred from title

liver metastasis

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

David Cunningham

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Ajith K Siriwardena

6

object named as

Ajith Siriwardena

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

ORCID Public Data File 2021

author name string

Stephen Falk

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Meg Finch-Jones

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Derek O'Reilly

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Joanne Hornbuckle

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Mark Peterson

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Myrddin Rees

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Tim Iveson

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Rachel Butler

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Elizabeth Dixon

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Louisa Little

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Megan Bowers

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Siân Pugh

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

O James Garden

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Tim Maughan

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

John Bridgewater

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

publication date

7 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

601-611

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC COIN trial experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A general inefficacy interim monitoring rule for randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Safe liver resection following chemotherapy for colorectal metastases is a matter of timing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab for the treatment of colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

HGF rescues colorectal cancer cells from EGFR inhibition via MET activation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970105-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(14)70105-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24717919%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61867795&oldid=1589178001"